The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

All News

Protective particles allow engineered probiotics to report gut disease
Biotics and Supplements

Protective particles allow engineered probiotics to report gut disease

SEP 12, 2023
Women’s Health in Microbiome Research
Pharma & Human Health

Women’s Health in Microbiome Research

SEP 5, 2023
Lonza’s Capsugel® Enprotect® capsule for effective enteric delivery
Pharma & Human Health

Lonza’s Capsugel® Enprotect® capsule for effective enteric delivery

AUG 31, 2023
Anti-bacterial virus treated antibiotic resistant infections with 86.6% success rate
Infectious Disease & AMR

Anti-bacterial virus treated antibiotic resistant infections with 86.6% success rate

AUG 24, 2023
Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023
Editor's Choice

Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023

AUG 22, 2023
New study asserts resB® Lung Support improves lung function through microbiome-mediated mechanisms along the gut-lung axis in asthmatic population
Pharma & Human Health

New study asserts resB® Lung Support improves lung function through microbiome-mediated mechanisms along the gut-lung axis in asthmatic population

AUG 22, 2023
Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial
Clinical & Manufacturing

Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial

AUG 18, 2023
A fungus gets comfortable: Aspergillus fumigatus adapts to life in humans and shapes their lung microbiome
Infectious Disease & AMR

A fungus gets comfortable: Aspergillus fumigatus adapts to life in humans and shapes their lung microbiome

AUG 17, 2023
Multiple sclerosis: fateful immune cell activation in gut made visible
Gut-Brain Axis

Multiple sclerosis: fateful immune cell activation in gut made visible

AUG 15, 2023
Engineered probiotic developed to treat multiple sclerosis
Biotics and Supplements

Engineered probiotic developed to treat multiple sclerosis

AUG 14, 2023
Bactolife Raises EUR 30 million in Series A Financing
Finance

Bactolife Raises EUR 30 million in Series A Financing

AUG 8, 2023